Is Bravecto safe for nursing dogs? - briefly
Bravecto is generally considered safe for use in nursing dogs when used according to label instructions. However, it's always recommended to consult with a veterinarian before administering any medication during lactation.
Is Bravecto safe for nursing dogs? - in detail
The safety of Bravecto for nursing dogs is an important concern for pet owners and veterinarians alike. Bravecto, also known as fluralaner, is a popular medication used to treat and prevent flea and tick infestations in dogs. While it has proven effective in adult animals, the question of its safety during lactation requires careful consideration.
Bravecto is classified as a systemic insecticide, which means it circulates throughout the body after administration. Once ingested, fluralaner is absorbed into the bloodstream and distributed to various tissues, including mammary glands. This distribution raises concerns about potential transfer of the drug into milk and its subsequent ingestion by nursing puppies.
Studies on the excretion of Bravecto in milk have shown that fluralaner is indeed excreted into the milk of lactating dogs. However, the concentration of the drug in milk is relatively low compared to the concentration in blood plasma. This suggests that while some amount of Bravecto may be transferred to puppies through nursing, the exposure is limited.
The primary concern with administering Bravecto to nursing dogs lies in the potential adverse effects on the puppies. Puppies are particularly vulnerable due to their immature physiological systems and rapid growth rates. The long half-life of fluralaner (approximately 12 days) means that it can persist in the body for an extended period, potentially affecting the developing puppies over time.
To date, there have been no extensive clinical studies specifically examining the effects of Bravecto on nursing dogs and their puppies. However, veterinary guidelines generally advise caution when using any medication during lactation. The potential risks to the puppies, including developmental issues or other adverse reactions, should be weighed against the benefits of treating the mother dog for fleas and ticks.
In cases where treatment with Bravecto is deemed necessary for a nursing dog, veterinarians may recommend temporarily separating the puppies from their mother until the drug has been sufficiently metabolized and excreted. This approach helps minimize the exposure of the puppies to the medication while still allowing the mother to receive the needed treatment.
In conclusion, while Bravecto is a safe and effective medication for adult dogs, its use during lactation should be approached with caution. The potential transfer of the drug into milk and the subsequent exposure of nursing puppies necessitate careful consideration and consultation with a veterinarian. Owners should weigh the benefits of treating the mother dog against the potential risks to her puppies and follow professional advice for the best outcomes.